Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Nesbitt

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Immunology|June 1, 1987
Functional heterogeneity of CD4+ T lymphocytes: two subpopulations with counteracting immunoregulatory functions identified with the monoclonal antibodies WR16 and WR19K Moore, A M Nesbitt
Immunology|August 1, 1986
Identification and isolation of OKT4+ suppressor cells with the monoclonal antibody WR16K Moore, A M Nesbitt
Immunology|January 1, 1990
Phenotypic changes in a CD4+ lymphocyte subset correlate with a conversion from suppressor to helper inducer functionA M Nesbitt, D B Jones, K Moore
Immunology|October 1, 1995
The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII bindingA Morgan, N D Jones, A M Nesbitt, et al.
Transplantation|July 13, 1999
Anti-major histocompatibility complex class II treatment prevents graft rejection in the hamster-to-rat cardiac xenograftN E Saxton, R V Hallaway, H M Ladyman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Immunology|June 1, 1987
Functional heterogeneity of CD4+ T lymphocytes: two subpopulations with counteracting immunoregulatory functions identified with the monoclonal antibodies WR16 and WR19K Moore, A M Nesbitt
Immunology|August 1, 1986
Identification and isolation of OKT4+ suppressor cells with the monoclonal antibody WR16K Moore, A M Nesbitt
Immunology|January 1, 1990
Phenotypic changes in a CD4+ lymphocyte subset correlate with a conversion from suppressor to helper inducer functionA M Nesbitt, D B Jones, K Moore
Immunology|October 1, 1995
The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII bindingA Morgan, N D Jones, A M Nesbitt, et al.
Transplantation|July 13, 1999
Anti-major histocompatibility complex class II treatment prevents graft rejection in the hamster-to-rat cardiac xenograftN E Saxton, R V Hallaway, H M Ladyman, et al.
Pageof 1